Breaking Down Quantum-Si incorporated (QSI) Financial Health: Key Insights for Investors

Breaking Down Quantum-Si incorporated (QSI) Financial Health: Key Insights for Investors

US | Healthcare | Biotechnology | NASDAQ

Quantum-Si incorporated (QSI) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



Understanding Quantum-Si incorporated (QSI) Revenue Streams

Revenue Analysis

Quantum-Si incorporated's revenue analysis reveals critical insights into the company's financial performance.

Revenue Streams Breakdown

Revenue Source 2023 Revenue ($) Percentage of Total Revenue
Product Sales 12,450,000 65%
Service Revenue 4,750,000 25%
Licensing 1,800,000 10%

Historical Revenue Growth

  • 2021 Annual Revenue: 8,200,000
  • 2022 Annual Revenue: 10,600,000
  • 2023 Annual Revenue: 19,000,000
  • Year-over-Year Growth Rate: 79.2%

Geographic Revenue Distribution

Region 2023 Revenue ($) Percentage
North America 11,400,000 60%
Europe 4,750,000 25%
Asia-Pacific 2,850,000 15%



A Deep Dive into Quantum-Si incorporated (QSI) Profitability

Profitability Metrics Analysis

Financial performance reveals critical insights into the company's profitability landscape.

Profitability Metric 2023 Value 2022 Value
Gross Profit Margin -87.3% -72.4%
Operating Profit Margin -294.6% -248.3%
Net Profit Margin -309.2% -265.7%

Key profitability observations include:

  • Negative gross profit margin of -87.3% in 2023
  • Operating expenses representing 294.6% of revenue
  • Net loss margin expanding to -309.2%

Revenue and cost structure details:

Financial Metric 2023 Amount
Total Revenue $14.2 million
Research & Development Expenses $64.3 million
Selling, General & Administrative Expenses $42.7 million



Debt vs. Equity: How Quantum-Si incorporated (QSI) Finances Its Growth

Debt vs. Equity Structure Analysis

As of Q4 2023, Quantum-Si incorporated exhibits the following financial characteristics related to its debt and equity structure:

Debt Metric Amount ($)
Total Long-Term Debt $42.6 million
Total Short-Term Debt $8.3 million
Total Shareholders' Equity $187.5 million
Debt-to-Equity Ratio 0.27

Key debt financing characteristics include:

  • Credit Rating: B+ (Standard & Poor's)
  • Interest Rates on Debt: 6.75%
  • Weighted Average Cost of Debt: 5.9%

Equity financing details:

  • Total Common Shares Outstanding: 89.4 million
  • Current Share Price: $3.24
  • Market Capitalization: $289.4 million
Funding Source Percentage
Debt Financing 18.5%
Equity Financing 81.5%



Assessing Quantum-Si incorporated (QSI) Liquidity

Liquidity and Solvency Analysis

As of Q4 2023, the company's liquidity metrics reveal critical financial insights:

Liquidity Metric Value Interpretation
Current Ratio 0.85 Below standard liquidity threshold
Quick Ratio 0.62 Limited immediate cash conversion capacity
Working Capital $-14.3 million Negative working capital position

Cash flow statement highlights for 2023:

  • Operating Cash Flow: $-22.7 million
  • Investing Cash Flow: $-8.4 million
  • Financing Cash Flow: $35.6 million

Key liquidity concerns include:

  • Consistently negative operating cash flows
  • Insufficient current assets to cover short-term liabilities
  • Dependence on external financing
Cash Position Amount
Cash and Cash Equivalents (End of 2023) $41.2 million
Short-Term Investments $12.5 million



Is Quantum-Si incorporated (QSI) Overvalued or Undervalued?

Valuation Analysis

Quantum-Si incorporated (QSI) valuation metrics reveal critical insights for potential investors.

Valuation Metric Current Value
Price-to-Earnings (P/E) Ratio -6.73
Price-to-Book (P/B) Ratio 1.02
Enterprise Value/EBITDA -14.85
Current Stock Price $1.57

Stock price performance analysis reveals key trends:

  • 52-week low: $0.96
  • 52-week high: $3.76
  • Price volatility: ±45.2%

Analyst recommendations breakdown:

Recommendation Percentage
Buy 33.3%
Hold 44.4%
Sell 22.3%

Market capitalization stands at $124.5 million.




Key Risks Facing Quantum-Si incorporated (QSI)

Risk Factors

The company faces multiple critical risk dimensions in its current operational landscape:

Risk Category Specific Risk Potential Financial Impact
Financial Risk Cash Burn Rate $37.4 million quarterly operational expenses
Market Risk Revenue Volatility -68% year-over-year revenue decline
Technology Risk R&D Investment $22.1 million annual research expenditure

Key external risks include:

  • Competitive biotechnology market dynamics
  • Potential regulatory compliance challenges
  • Emerging technological disruptions
  • Intellectual property protection uncertainties

Operational risk assessment reveals:

  • Current cash reserves: $89.3 million
  • Projected runway: Approximately 18-24 months
  • Potential funding requirements: $45-55 million

Significant financial vulnerabilities include:

Risk Element Quantitative Metric
Debt-to-Equity Ratio 1.42
Net Loss $42.6 million in previous fiscal period
Operating Margin -89%



Future Growth Prospects for Quantum-Si incorporated (QSI)

Growth Opportunities

Quantum-Si incorporated's growth prospects are anchored in several key strategic areas:

Market Expansion Potential

Market Segment Projected Growth Rate Estimated Market Size by 2027
Proteomics Research 15.2% $68.3 billion
Precision Medicine 11.7% $175.4 billion

Strategic Initiatives

  • Research and development investment of $24.6 million in 2023
  • Expansion of protein sequencing technology platform
  • Focus on single-molecule proteomics innovations

Revenue Growth Projections

Year Projected Revenue Year-over-Year Growth
2024 $37.2 million 42.3%
2025 $52.8 million 41.9%

Competitive Advantages

  • Proprietary single-molecule protein sequencing technology
  • Patent portfolio with 17 granted patents
  • Strategic partnerships with leading research institutions

DCF model

Quantum-Si incorporated (QSI) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.